Condition
Cow Milk Protein Allergy
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Recruiting1
Terminated1
Enrolling By Invitation1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06633250Not ApplicableRecruitingPrimary
Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy.
NCT07242950CompletedPrimary
Effect of Elimination Diet on Intestinal Mucus Barrier in Infants With Cow's Milk Protein Allergy
NCT06830681Not ApplicableTerminatedPrimary
CMPA-GO Study: Growth and Safety Outcomes in Infants With CMPA Fed a Novel Extensively Hydrolyzed Formula
NCT06998225Not ApplicableCompletedPrimary
Tolerance to Baked Goods in Allergic Children
NCT06673082Not ApplicableEnrolling By InvitationPrimary
Impact of Zinc as a New Adjuvant Therapy for Cow Milk Protein Allergy in Children.
Showing all 5 trials